Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)
Bangladesh
· Delayed Price · Currency is BDT 731.30
-16.20 (-2.17%)
At close: Dec 4, 2025
Ambee Pharmaceuticals Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 31.65 | 32.64 | 32.74 | 28.57 | 16.92 | 15.09 | Upgrade
|
| Short-Term Investments | 100 | 100 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 131.65 | 132.64 | 32.74 | 28.57 | 16.92 | 15.09 | Upgrade
|
| Cash Growth | 295.40% | 305.12% | 14.61% | 68.81% | 12.12% | 35.79% | Upgrade
|
| Receivables | 202.65 | 194.84 | 180.65 | 135.94 | 112.51 | 92.23 | Upgrade
|
| Inventory | 228.74 | 210.8 | 221.91 | 197.25 | 178.89 | 128.89 | Upgrade
|
| Prepaid Expenses | - | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Other Current Assets | 38.64 | 39.27 | 69.52 | 64.65 | 100.76 | 85.62 | Upgrade
|
| Total Current Assets | 601.68 | 577.57 | 504.84 | 426.44 | 409.11 | 321.85 | Upgrade
|
| Property, Plant & Equipment | 101.06 | 103.38 | 85.1 | 87.61 | 95.04 | 99.56 | Upgrade
|
| Long-Term Investments | 52.6 | 52.6 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | - | - | - | - | - | 0 | Upgrade
|
| Total Assets | 755.34 | 733.56 | 589.94 | 514.05 | 504.15 | 421.42 | Upgrade
|
| Accounts Payable | 6.09 | 6.13 | 5.59 | 4.98 | 6.55 | 7.22 | Upgrade
|
| Accrued Expenses | 10.13 | 31.72 | 20.23 | 19.65 | 53.02 | 79.04 | Upgrade
|
| Short-Term Debt | 682.56 | 638.5 | - | 392.35 | 343.8 | 235.67 | Upgrade
|
| Current Portion of Leases | 0.14 | 0.24 | 0.6 | 0.13 | 1.07 | 2.75 | Upgrade
|
| Current Income Taxes Payable | 18.69 | 18.41 | 25.16 | 31.54 | 36.34 | 38.44 | Upgrade
|
| Current Unearned Revenue | - | - | 4.62 | - | - | - | Upgrade
|
| Other Current Liabilities | 0.38 | 2.18 | 499.56 | 35.93 | 3.49 | 5 | Upgrade
|
| Total Current Liabilities | 717.99 | 697.17 | 555.76 | 484.59 | 444.27 | 368.12 | Upgrade
|
| Long-Term Leases | 0.19 | 0.2 | 0.24 | - | 0.01 | 1.42 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.63 | 3.85 | 4.51 | 6.12 | 7.17 | 7.04 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0 | - | - | Upgrade
|
| Total Liabilities | 721.81 | 701.22 | 560.52 | 490.71 | 451.45 | 376.58 | Upgrade
|
| Common Stock | 24 | 24 | 24 | 24 | 24 | 24 | Upgrade
|
| Retained Earnings | 9.53 | 8.33 | 5.42 | -0.66 | 28.7 | 20.84 | Upgrade
|
| Shareholders' Equity | 33.53 | 32.33 | 29.42 | 23.34 | 52.7 | 44.84 | Upgrade
|
| Total Liabilities & Equity | 755.34 | 733.56 | 589.94 | 514.05 | 504.15 | 421.42 | Upgrade
|
| Total Debt | 682.89 | 638.94 | 0.84 | 392.48 | 344.88 | 239.85 | Upgrade
|
| Net Cash (Debt) | -551.24 | -506.3 | 31.9 | -363.91 | -327.96 | -224.75 | Upgrade
|
| Net Cash Per Share | -229.68 | -210.96 | 13.29 | -151.63 | -136.65 | -93.65 | Upgrade
|
| Filing Date Shares Outstanding | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | Upgrade
|
| Total Common Shares Outstanding | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | Upgrade
|
| Working Capital | -116.31 | -119.6 | -50.92 | -58.15 | -35.17 | -46.26 | Upgrade
|
| Book Value Per Share | 13.97 | 13.47 | 12.26 | 9.73 | 21.96 | 18.68 | Upgrade
|
| Tangible Book Value | 33.53 | 32.33 | 29.42 | 23.34 | 52.7 | 44.84 | Upgrade
|
| Tangible Book Value Per Share | 13.97 | 13.47 | 12.26 | 9.73 | 21.96 | 18.68 | Upgrade
|
| Land | - | 50.25 | 50.25 | 50.25 | 50.25 | 50.25 | Upgrade
|
| Buildings | - | 29.95 | 29.95 | 29.95 | 29.95 | 29.08 | Upgrade
|
| Machinery | - | 174.25 | 150.46 | 148.26 | 148.15 | 147.49 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.